BMSC-EXO-derived miR-146a reduces NF-κB levels [80], while BMSC-EXO-derived growth differentiation factor 15 alleviates SH-SY5Y cell damage in an AD model via the AKT/GSK-3β/β-catenin pathway [84]. This evidence concerns the gene NFKB1 and Alzheimer disease.